Advanced therapies are pressuring reimbursement and necessitating real-world durability data and new payment models, said ...
Specialty pharmacy workflows must account for longer, more complex affordability calls, with copay-shock interactions ...
Rose Gerber, MS, director of patient advocacy and education at the Community Oncology Alliance (COA) Patient Advocacy Network ...
Innovations in pharmacy are already delivering results, but there is still work to do to evolve the ecosystem, said Ryan ...
Randomized assignment to trabeculectomy versus drops enabled comparative assessment of visual field, IOP, and ...
Adoption metrics show a wide gap between declared AI priority and production deployment in health care, compounded by limited ...
Lekan Ajayi, PharmD, explains how remote therapy monitoring keeps patients with cancer on track with their care and reduces ...
For Diana Verrilli, MS, senior vice president and general manager of Navista, the Community Oncology Alliance’s newly ...
Expanding CAR T beyond academic centers is primarily an access imperative, as travel distance and authorized-site ...
Flatiron EHR-derived data from >220 community practices (~40% of US community oncologists) were analyzed for de novo stage IV ...
Retrospective analysis evaluated systematic asymptomatic screening using saliva PCR, with most tests performed within 72 ...
Drug pricing transparency and easy discounts cut abandoned prescriptions, as federal policies put pressure on pharma, says ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results